{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:00:54Z","timestamp":1791939654955,"version":"4.3.4"},"reference-count":138,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","award":["Pro00094712"],"award-info":[{"award-number":["Pro00094712"]}],"id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cjco.2023.12.010","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T07:19:00Z","timestamp":1702711140000},"page":"314-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"PB","title":["Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7816-3422","authenticated-orcid":false,"given":"Donna","family":"Vine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahua","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Bakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2023.12.010_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","article-title":"Beyond fertility: polycystic ovary syndrome and long-term health","volume":"110","author":"Cooney","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib3","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cjco.2023.12.010_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/IJWH.S165794","article-title":"Measures of health-related quality of life in PCOS women: a systematic review","volume":"10","author":"Behboodi Moghadam","year":"2018","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.cjco.2023.12.010_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Reproductive endocrinology and infertility: clinical expert series polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cjco.2023.12.010_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen Excess-Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib8","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deab101","article-title":"Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years","volume":"36","author":"Fernandez","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cjco.2023.12.010_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/09513590600604541","article-title":"Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36)","volume":"22","author":"Coffey","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cjco.2023.12.010_bib10","doi-asserted-by":"crossref","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","article-title":"Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study","volume":"106","author":"Berni","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cjco.2023.12.010_bib12","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/humrep\/deu200","article-title":"Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study","volume":"29","author":"West","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cjco.2023.12.010_bib13","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/ijamh-2021-0031","article-title":"Polycystic ovary syndrome and reproductive health of women: a curious association","volume":"33","author":"Zehravi","year":"2021","journal-title":"Int J Adolesc Med Health"},{"key":"10.1016\/j.cjco.2023.12.010_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.fertnstert.2018.08.058","article-title":"Infertility: a marker of future health risk in women?","volume":"10","author":"Senapti","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib16","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1210\/jc.2010-1709","article-title":"Menstrual irregularity and cardiovascular mortality","volume":"96","author":"Wang","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib17","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1210\/jc.2017-01354","article-title":"Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome","volume":"102","author":"Rubin","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cjco.2023.12.010_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cjco.2023.12.010_bib20","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/obr.12829","article-title":"Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity-A systematic review, meta-analysis, and meta-regression","volume":"20","author":"Bahri Khomami","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.cjco.2023.12.010_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cjco.2023.12.010_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.23736\/S0026-4784.18.04230-2","article-title":"Pregnancy complications in infertile patients with polycystic ovary syndrome: updated evidence","volume":"70","author":"Palomba","year":"2018","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.cjco.2023.12.010_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A\u00a0meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cjco.2023.12.010_bib25","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1210\/jc.2013-2007","article-title":"Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome","volume":"99","author":"Joham","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0041-1726866","article-title":"Obesity and the risk of infertility, gestational diabetes, and type 2 diabetes in polycystic ovary syndrome","volume":"38","author":"Pirotta","year":"2020","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/clinem\/dgab613","article-title":"Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences","volume":"107","author":"Riestenberg","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib28","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1017\/S0033291718002076","article-title":"Depression, anxiety and perceived stress in women with and without PCOS: a community-based study","volume":"49","author":"Damone","year":"2019","journal-title":"Psychol Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85338","article-title":"Direct economic burden of mental health disorders associated with polycystic ovary syndrome: systematic review and meta-analysis","volume":"12","author":"Yadav","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.cjco.2023.12.010_bib30","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1007\/s43032-023-01285-x","article-title":"A\u00a0systematic review of the psychosocial impact of polycystic ovarian syndrome before and after treatment","volume":"30","author":"Rempert","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.cjco.2023.12.010_bib31","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.JIM.0000446834.90599.5d","article-title":"Epidemiology and comorbidities of PCOS in an indigent population","volume":"62","author":"Sirmans","year":"2014","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/EJE-14-1108","article-title":"Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome","volume":"172","author":"Glintborg","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cjco.2023.12.010_bib33","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2012-1690","article-title":"Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study","volume":"97","author":"Morgan","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1345\/aph.1Q514","article-title":"Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications","volume":"46","author":"Sirmans","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cjco.2023.12.010_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cen.14558","article-title":"The impact of ageing and menopause in women with polycystic ovary syndrome","volume":"97","author":"Helvaci","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cjco.2023.12.010_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmad015","article-title":"PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis","volume":"29","author":"Mill\u00e1n-de-Meer","year":"2023","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cjco.2023.12.010_bib37","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam study","volume":"103","author":"Meun","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib38","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2018-00941","article-title":"Patterns of cardiometabolic health as midlife women transition to menopause: a prospective multiethnic study","volume":"104","author":"Ward","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/jwh.2015.5441","article-title":"Cardiovascular disease abd 10-year mortaility in postmenopausal women with clinical features of polycystic ovary syndrome","volume":"25","author":"Merz","year":"2016","journal-title":"J Womens Health"},{"key":"10.1016\/j.cjco.2023.12.010_bib40","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0038-1668086","article-title":"The needs of women and healthcare providers regarding polycystic ovary syndrome information, resources, and education: a systematic search and narrative review","volume":"36","author":"Gibson-Helm","year":"2018","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib42","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.pec.2021.05.038","article-title":"The challenges with managing polycystic ovary syndrome: a qualitative study of women's and clinicians' experiences","volume":"105","author":"Copp","year":"2022","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.cjco.2023.12.010_bib43","doi-asserted-by":"crossref","DOI":"10.2196\/16541","article-title":"Measures of patient dissatisfaction with health care in polycystic ovary syndrome: retrospective analysis","volume":"22","author":"Hoyos","year":"2020","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.cjco.2023.12.010_bib44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1186\/s12905-023-02732-2","article-title":"Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care","volume":"23","author":"Sydora","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.cjco.2023.12.010_bib45","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1210\/jc.2017-01415","article-title":"Perspectives on polycystic ovary syndrome: Is polycystic ovary syndrome research underfunded?","volume":"102","author":"Brakta","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3747\/co.26.4399","article-title":"A\u00a0population-level comparison of cancer-related and non-cancer related health care costs using publicly available provincial administrative data","volume":"26","author":"Sam","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.cjco.2023.12.010_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12911-015-0155-5","article-title":"Methods for identifying 30 chronic conditions: application to administrative data","volume":"15","author":"Tonelli","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.cjco.2023.12.010_bib48","article-title":"Disparities in adherence to diabetes screening guidelines among males and females in a universal care setting: a population-based study of 1,380,697 adults","volume":"14","author":"Kaul","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.cjco.2023.12.010_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cardfail.2021.08.016","article-title":"The incidence and prevalence of cardiac amyloidosis in a large community-based cohort in Alberta, Canada","volume":"28","author":"Sepehrvand","year":"2022","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjco.2023.12.010_bib51","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.cjco.2023.12.010_bib52","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/HYPERTENSIONAHA.109.139279","article-title":"Validation of a case definition to define hypertension using administrative data","volume":"54","author":"Quan","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2023.12.010_bib53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.cjco.2023.12.010_bib54","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/1475-6773.00165","article-title":"Improved comorbidity adjustment for predicting mortality in Medicare populations","volume":"38","author":"Schneeweiss","year":"2003","journal-title":"Health Serv Res"},{"key":"10.1016\/j.cjco.2023.12.010_bib55","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/humrep\/dez185","article-title":"Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource","volume":"34","author":"Azziz","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cjco.2023.12.010_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/clinem\/dgaa675","article-title":"Characterizing the clinical and genetic spectrum of PCOS in electronic health records","volume":"106","author":"Actkins","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12958-015-0115-z","article-title":"Identification of subjects with polycystic ovary syndrome using electronic health care records","volume":"13","author":"Castro","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.cjco.2023.12.010_bib58","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and managment of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"key":"10.1016\/j.cjco.2023.12.010_bib60","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.6004","article-title":"A\u00a0comparison of 12 algorithms for matching on the propensity score","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil.Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib62","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An International Consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.cjco.2023.12.010_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cen.14421","article-title":"Obesity and polycystic ovary syndrome","volume":"95","author":"Barber","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cjco.2023.12.010_bib66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.cjco.2023.12.010_bib67","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"90","author":"Carmina","year":"2005","journal-title":"J\u00a0Clin Endocrinol.Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-022-02238-y","article-title":"Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis","volume":"20","author":"Liu","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.24095\/hpcdp.34.1.06","article-title":"Metabolic syndrome and chronic disease","volume":"34","author":"Rao","year":"2014","journal-title":"Chronic Dis Inj Can"},{"key":"10.1016\/j.cjco.2023.12.010_bib70","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40200-022-01124-x","article-title":"Association between liver enzymes and metabolic syndrome in Canadian adults: results from the Canadian health measures survey\u2014cycles 3 & 4","volume":"21","author":"Chu","year":"2022","journal-title":"J\u00a0Diabetes Metab Disord"},{"key":"10.1016\/j.cjco.2023.12.010_bib71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcjd.2023.08.008","article-title":"Impact of sex and gender on metabolic syndrome in adults: a retrospective cohort study from the Canadian Primary Care Sentinel Surveillance Network","volume":"48","author":"Dev","year":"2023","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.cjco.2023.12.010_bib72","doi-asserted-by":"crossref","first-page":"e1127","DOI":"10.1503\/cmaj.110070","article-title":"Prevalence of metabolic syndrome in the Canadian adult population","volume":"183","author":"Riediger","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.cjco.2023.12.010_bib73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1742-1241.2008.01897.x","article-title":"Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome","volume":"63","author":"Berneis","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.cjco.2023.12.010_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1990.tb00472.x","article-title":"The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women","volume":"33","author":"Graf","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cjco.2023.12.010_bib75","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.fertnstert.2008.06.004","article-title":"Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels","volume":"92","author":"Fruzzetti","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib76","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.steroids.2011.12.002","article-title":"Dyslipidemia in PCOS","volume":"77","author":"Wild","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.cjco.2023.12.010_bib77","article-title":"ApoB48-lipoproteins are associated with cardiometabolic risk in adolescents with and without polycystic ovary syndrome","volume":"4","author":"Vine","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.cjco.2023.12.010_bib78","first-page":"970","article-title":"Impaired ApoB-lipoprotein and triglyceride metabolism in obese adolescents with polycystic ovary syndrome","volume":"102","author":"Vine","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib79","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib80","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jadohealth.2009.10.008","article-title":"Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome","volume":"46","author":"Fulghesu","year":"2010","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1016\/j.cjco.2023.12.010_bib81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1139\/Y08-014","article-title":"Lipid and lipoprotein profile in women with polycystic ovary syndrome","volume":"86","author":"Macut","year":"2008","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.cjco.2023.12.010_bib82","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.fertnstert.2006.11.031","article-title":"Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome","volume":"87","author":"Bahceci","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib83","doi-asserted-by":"crossref","first-page":"bvab114","DOI":"10.1210\/jendso\/bvab114","article-title":"A\u00a0pilot trial: fish oil and metformin effects on ApoB-remnants and triglycerides in women with polycystic ovary syndrome","volume":"5","author":"Vine","year":"2021","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.cjco.2023.12.010_bib84","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2023.12.010_bib85","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ana.22384","article-title":"Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population","volume":"69","author":"Varbo","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cjco.2023.12.010_bib86","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/humupd\/dmr046","article-title":"Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Meyer","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cjco.2023.12.010_bib87","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1210\/jc.2004-2363","article-title":"Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome","volume":"90","author":"Vryonidou","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib88","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.fertnstert.2007.11.057","volume":"91","author":"Arikan","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232299","article-title":"Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles","volume":"15","author":"Jabbour","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cjco.2023.12.010_bib90","series-title":"Paper presented at: Canadian Women\u2019s Heart Health Summit","article-title":"Early subclinical cardiovascular disease is associated with elevated remnant cholesterol and ApoB-lipoproteins in young women with and without polycystic ovary syndrome","author":"Wu","year":"2023"},{"key":"10.1016\/j.cjco.2023.12.010_bib91","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.cjco.2023.12.010_bib92","first-page":"S9","article-title":"The 2023 impact of inflammatory bowel disease in Canada: epidemiology of IBD","volume":"6","author":"Coward","year":"2023","journal-title":"J\u00a0Can Assoc Gastroenterol"},{"key":"10.1016\/j.cjco.2023.12.010_bib93","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2023.2239933","article-title":"A\u00a0systematic review and meta-analysis of the correlation between polycystic ovary syndrome and irritable bowel syndrome","volume":"39","author":"Wei","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cjco.2023.12.010_bib94","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12955-020-01428-7","article-title":"The impact of irritable bowel syndrome on health-related quality of life in women with polycystic ovary syndrome","volume":"18","author":"Bazarganipour","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.cjco.2023.12.010_bib95","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10620-009-0890-5","article-title":"Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome","volume":"55","author":"Mathur","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cjco.2023.12.010_bib96","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications","volume":"13","author":"Sun","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cjco.2023.12.010_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.808508","article-title":"Gut and vaginal microbiomes in PCOS: implications for women's health","volume":"13","author":"Gu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.cjco.2023.12.010_bib98","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cjco.2023.12.010_bib99","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12902-023-01456-6","article-title":"Hepatic steatosis in women with polycystic ovary syndrome","volume":"23","author":"Hong","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.cjco.2023.12.010_bib100","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/hep4.2039","article-title":"Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age","volume":"6","author":"Maldonado","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cjco.2023.12.010_bib101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/biomedicines10010131","article-title":"Prevalence, risk factors, and pathophysiology of nonalcoholic fatty liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS)","volume":"10","author":"Spremovi\u0107 Ra\u0111enovi\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cjco.2023.12.010_bib102","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/ajo.13168","article-title":"Trends in metabolic surgery in reproductive-age women in Australia","volume":"60","author":"Skalecki","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.cjco.2023.12.010_bib103","first-page":"856","article-title":"Non-alcoholic fatty liver disease in patients with polycystic ovary syndrome: a systematic review, meta-analysis, and meta-regression","volume":"12","author":"Manzano-Nunez","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib104","first-page":"414","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovarian syndrome: a narrative review","volume":"75","author":"DeHaan","year":"2022","journal-title":"S\u00a0D Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3345\/cep.2023.00353","article-title":"Relationship between non-alcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome","volume":"66","author":"Kara","year":"2023","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.cjco.2023.12.010_bib106","first-page":"557","article-title":"The burden of non-alcoholic fatty liver disease in adolescents with polycystic ovary syndrome: a case-control study","volume":"12","author":"Giannouli","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib107","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.dsx.2018.12.020","article-title":"Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"13","author":"Varma","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.cjco.2023.12.010_bib108","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib109","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cjco.2023.12.010_bib110","first-page":"4182","article-title":"High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus","volume":"85","author":"Escobar-Morreale","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib111","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/EJE-11-0670","article-title":"High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profiles","volume":"166","author":"Samara-Boustani","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cjco.2023.12.010_bib112","first-page":"524","article-title":"Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls","volume":"75","author":"Kjaer","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib113","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/dmac011","article-title":"Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis","volume":"28","author":"Bayona","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cjco.2023.12.010_bib114","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/dc15-2577","article-title":"Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis","volume":"39","author":"Escobar-Morreale","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjco.2023.12.010_bib115","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1210\/jc.2006-2641","article-title":"Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus","volume":"92","author":"Codner","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib116","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/09513590.2017.1347779","article-title":"Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis","volume":"33","author":"Zhou","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cjco.2023.12.010_bib117","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib118","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jacc.2022.08.759","article-title":"Canadian spontaneous coronary artery dissection cohort study: 3-year outcomes","volume":"80","author":"Saw","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2023.12.010_bib119","article-title":"Associations between asthma and polycystic ovary syndrome: current perspectives","volume":"13","author":"Xu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.cjco.2023.12.010_bib120","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2222.2008.03197.x","article-title":"Insulin resistance as a predictor of incident asthma-like symptoms in adults","volume":"39","author":"Thuesen","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.cjco.2023.12.010_bib121","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.3390\/ijms24086959","article-title":"The \"asthma-polycystic ovary overlap syndrome\" and the therapeutic role of myo-inositol","volume":"24","author":"Guarnieri","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cjco.2023.12.010_bib122","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01334-2016","article-title":"Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"49","author":"Htet","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjco.2023.12.010_bib124","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/00369330221107099","article-title":"Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: an updated meta-analysis","volume":"67","author":"Li","year":"2022","journal-title":"Scott Med J"},{"key":"10.1016\/j.cjco.2023.12.010_bib125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3892\/ol.2023.13754","article-title":"Risk of endometrial cancer in patients with polycystic ovarian syndrome: a meta-analysis","volume":"25","author":"Johnson","year":"2023","journal-title":"Oncol Lett"},{"key":"10.1016\/j.cjco.2023.12.010_bib126","first-page":"893","article-title":"Risk of endometrial, ovarian, and breast cancers in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Amiri","year":"2022","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.cjco.2023.12.010_bib127","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.psyneuen.2016.08.005","article-title":"Polycystic ovary syndrome and psychiatric disorders: co-morbidity and heritability in a nationwide Swedish cohort","volume":"73","author":"Cesta","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.cjco.2023.12.010_bib128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12020-018-1692-3","article-title":"Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"62","author":"Brutocao","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.cjco.2023.12.010_bib129","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cjco.2023.12.010_bib130","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/jc.2017-02667","article-title":"Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes","volume":"103","author":"Berni","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.appet.2016.11.010","article-title":"Binge eating behaviours and food cravings in women with polycystic ovary syndrome","volume":"109","author":"Jeanes","year":"2017","journal-title":"Appetite"},{"key":"10.1016\/j.cjco.2023.12.010_bib132","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40519-018-0533-y","article-title":"Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Lee","year":"2019","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.cjco.2023.12.010_bib133","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.fertnstert.2016.12.014","article-title":"Increased risk of disordered eating in polycystic ovary syndrome","volume":"107","author":"Lee","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib134","first-page":"1682","article-title":"Disordered eating behaviours and eating disorders in women in Australia with and without polycystic ovary syndrome: a cross-sectional study","volume":"8","author":"Pirotta","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjco.2023.12.010_bib135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-277X.2008.00890.x","article-title":"An retrospective audit of patients with polycystic ovary syndrome: the effects of a reduced glycaemic load diet","volume":"21","author":"Herriot","year":"2008","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1016\/j.cjco.2023.12.010_bib136","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0015-0282(02)03063-7","article-title":"Polycystic ovarian morphology and bulimia nervosa: a 9-year follow-up study","volume":"77","author":"Morgan","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cjco.2023.12.010_bib137","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.fertnstert.2019.03.027","article-title":"Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort study","volume":"112","author":"Tay","year":"2019","journal-title":"Fertil Steril"},{"issue":"Supp1","key":"10.1016\/j.cjco.2023.12.010_bib138","first-page":"S9","article-title":"A\u00a0scoping review of eating disorders in women with polycystic ovarian syndrome [abstract]","volume":"48","author":"Lalonde-Bester","year":"2023","journal-title":"Appl Nutr and Metab"},{"key":"10.1016\/j.cjco.2023.12.010_bib139","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12978-021-01203-x","article-title":"Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review","volume":"18","author":"Sarahian","year":"2021","journal-title":"Reprod Health"},{"key":"10.1016\/j.cjco.2023.12.010_bib140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson Comorbidity Index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X23003785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X23003785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:14:18Z","timestamp":1762902858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X23003785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2589790X23003785"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2023.12.010","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}